Thu, 10 May 2012
Molecular Markers in Lung Cancer Pt 5: Dr. David Spigel on Incorporating Targets into Clinical Trials (audio)
Dr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include patient subgroups based on molecular markers.
Direct download: GRACEcast-100_Lung-Audio_MMiLC_Panel_Discussion_pt5.mp3
Category:Lung-Cancer-Audio -- posted at: 3:22pm PDT